课题基金 / 基金详情

SodiUm Glucose co-trAnspoRt-2 inhibitioN diabeteS And and kidney function Loss in Type 1 diabetes: The "SUGARNSALT" Team Grant Program

SodiUm Glucose co-trAnspoRt-2 inhibitioN diabeteS And and kidney function Loss in Type 1 diabetes: The "SUGARNSALT" Team Grant Program
钠葡萄糖协同转运 2 抑制糖尿病和 1 型糖尿病肾功能丧失：“SUGARNSALT”团队资助计划
批准号：
446716
负责人：
Cherney David Z
金额：
$0.73万
依托单位：
Toronto General Hospital
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2020
资助国家：
加拿大
项目状态：
已结题
起止时间：
2020-12-01 至 2021-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=446716&lang=en
关键词：
Albuminuria Biological Sex Blood Pressure Cardiovascular Disease Diabetes Gfr Slope Glycemic Control Kidney Health And Disease Patient Oriented Research Sglt2 Inhibition

项目摘要

项目成果

Cherney David Z的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Diabetes is the most common cause of kidney failure in Canada, and requires either dialysis or a kidney transplant. Kidney failure leads to terrible suffering for patients, with a poor quality of life, equivalent to that seen with advanced colon cancer. I
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SodiUm Glucose co-trAnspoRt-2 inhibitioN diabeteS And and kidney function Loss in Type 1 diabetes: The "SUGARNSALT" Team Grant Program
  • 批准号：
    454370
  • 项目类别：
    Operating Grants
  • 资助金额：
    $72.32万
  • 财政年份：
    2021
  • 负责人：
    Cherney David Z
  • 依托单位：
    University Health Network (Toronto)
Blockade of acE and Treatment With Empagliflozin - Effects on hyperfiltratioN in Type 1 Diabetes: The BETWEEN-T1D Study
  • 批准号：
    304448
  • 项目类别：
    Operating Grants
  • 资助金额：
    $53.29万
  • 财政年份：
    2014
  • 负责人：
    Cherney David Z
  • 依托单位：
    University Health Network (Toronto)
A Deep Phenotyping Approach to Assess the Effect of Uric Acid Lowering in Patients with Uncomplicated Type 1 Diabetes Mellitus
  • 批准号：
    279793
  • 项目类别：
    Operating Grants
  • 资助金额：
    $24.12万
  • 财政年份：
    2013
  • 负责人：
    Cherney David Z
  • 依托单位：
    University Health Network (Toronto)
海外基金